Literature DB >> 19542527

Are screening instruments valid for psychotic-like experiences? A validation study of screening questions for psychotic-like experiences using in-depth clinical interview.

Ian Kelleher1, Michelle Harley, Aileen Murtagh, Mary Cannon.   

Abstract

Individuals who report psychotic-like experiences are at increased risk of future clinical psychotic disorder. They constitute a unique "high-risk" group for studying the developmental trajectory to schizophrenia and related illnesses. Previous research has used screening instruments to identify this high-risk group, but the validity of these instruments has not yet been established. We administered a screening questionnaire with 7 items designed to assess psychotic-like experiences to 334 adolescents aged 11-13 years. Detailed clinical interviews were subsequently carried out with a sample of these adolescents. We calculated sensitivity and specificity and positive predictive value (PPV) and negative predictive value (NPV) for each screening question for the specific symptom it enquired about and also in relation to any psychotic-like experience. The predictive power varied substantially between items, with the question on auditory hallucinations ("Have you ever heard voices or sounds that no one else can hear?") providing the best predictive power. For interview-verified auditory hallucinations specifically, this question had a PPV of 71.4% and an NPV of 90.4%. When assessed for its predictive power for any psychotic-like experience (including, but not limited to, auditory hallucinations), it provided a PPV of 100% and an NPV of 88.4%. Two further questions-relating to visual hallucinations and paranoid thoughts-also demonstrated good predictive power for psychotic-like experiences. Our results suggest that it may be possible to screen the general adolescent population for psychotic-like experiences with a high degree of accuracy using a short self-report questionnaire.

Entities:  

Mesh:

Year:  2009        PMID: 19542527      PMCID: PMC3044617          DOI: 10.1093/schbul/sbp057

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  24 in total

1.  The distribution of positive psychosis-like symptoms in the population: a latent class analysis of the National Comorbidity Survey.

Authors:  Mark Shevlin; Jamie Murphy; Martin J Dorahy; Gary Adamson
Journal:  Schizophr Res       Date:  2006-11-09       Impact factor: 4.939

2.  North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research.

Authors:  Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming Tsuang; Elaine F Walker; Scott W Woods; Robert Heinssen
Journal:  Schizophr Bull       Date:  2007-01-25       Impact factor: 9.306

3.  Self-reported psychotic symptoms in the general population: results from the longitudinal study of the British National Psychiatric Morbidity Survey.

Authors:  Nicola J Wiles; Stanley Zammit; Paul Bebbington; Nicola Singleton; Howard Meltzer; Glyn Lewis
Journal:  Br J Psychiatry       Date:  2006-06       Impact factor: 9.319

4.  Strauss (1969) revisited: a psychosis continuum in the general population?

Authors:  J van Os; M Hanssen; R V Bijl; A Ravelli
Journal:  Schizophr Res       Date:  2000-09-29       Impact factor: 4.939

5.  Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study.

Authors:  R Poulton; A Caspi; T E Moffitt; M Cannon; R Murray; H Harrington
Journal:  Arch Gen Psychiatry       Date:  2000-11

Review 6.  A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder.

Authors:  J van Os; R J Linscott; I Myin-Germeys; P Delespaul; L Krabbendam
Journal:  Psychol Med       Date:  2008-07-08       Impact factor: 7.723

7.  Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America.

Authors:  Tyrone D Cannon; Kristin Cadenhead; Barbara Cornblatt; Scott W Woods; Jean Addington; Elaine Walker; Larry J Seidman; Diana Perkins; Ming Tsuang; Thomas McGlashan; Robert Heinssen
Journal:  Arch Gen Psychiatry       Date:  2008-01

8.  Subclinical psychotic experiences and cognitive functioning as a bivariate phenotype for genetic studies in the general population.

Authors:  C J P Simons; N Jacobs; J Jolles; J van Os; L Krabbendam
Journal:  Schizophr Res       Date:  2007-03-07       Impact factor: 4.939

9.  IQ and non-clinical psychotic symptoms in 12-year-olds: results from the ALSPAC birth cohort.

Authors:  Jeremy Horwood; Giovanni Salvi; Kate Thomas; Larisa Duffy; David Gunnell; Chris Hollis; Glyn Lewis; Paulo Menezes; Andrew Thompson; Dieter Wolke; Stanley Zammit; Glynn Harrison
Journal:  Br J Psychiatry       Date:  2008-09       Impact factor: 9.319

10.  Associations between childhood trauma, bullying and psychotic symptoms among a school-based adolescent sample.

Authors:  Ian Kelleher; Michelle Harley; Fionnuala Lynch; Louise Arseneault; Carol Fitzpatrick; Mary Cannon
Journal:  Br J Psychiatry       Date:  2008-11       Impact factor: 9.319

View more
  78 in total

1.  Identification and characterization of prodromal risk syndromes in young adolescents in the community: a population-based clinical interview study.

Authors:  Ian Kelleher; Aileen Murtagh; Charlene Molloy; Sarah Roddy; Mary C Clarke; Michelle Harley; Mary Cannon
Journal:  Schizophr Bull       Date:  2011-11-17       Impact factor: 9.306

2.  Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms.

Authors:  Sonia Dollfus; Cyril Mach; Rémy Morello
Journal:  Schizophr Bull       Date:  2015-11-12       Impact factor: 9.306

3.  Examining Specificity of Neural Correlates of Childhood Psychotic-like Experiences During an Emotional n-Back Task.

Authors:  Kathleen J O'Brien; Deanna M Barch; Sridhar Kandala; Nicole R Karcher
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-03-19

4.  Evidence that onset of psychosis in the population reflects early hallucinatory experiences that through environmental risks and affective dysregulation become complicated by delusions.

Authors:  Feikje Smeets; Tineke Lataster; Maria-de-Gracia Dominguez; Juliette Hommes; Roselind Lieb; Hans-Ullrich Wittchen; Jim van Os
Journal:  Schizophr Bull       Date:  2010-10-28       Impact factor: 9.306

5.  'False-positive' self-reported psychotic experiences in the general population: an investigation of outcome, predictive factors and clinical relevance.

Authors:  Y van der Steen; I Myin-Germeys; M van Nierop; M Ten Have; R de Graaf; S van Dorsselaer; J van Os; R van Winkel
Journal:  Epidemiol Psychiatr Sci       Date:  2018-04-16       Impact factor: 6.892

6.  Cerebellar Transcranial Direct Current Stimulation Improves Procedural Learning in Nonclinical Psychosis: A Double-Blind Crossover Study.

Authors:  Tina Gupta; Derek J Dean; Nicholas J Kelley; Jessica A Bernard; Ivanka Ristanovic; Vijay A Mittal
Journal:  Schizophr Bull       Date:  2018-10-17       Impact factor: 9.306

7.  Association of Cannabis Use With Adolescent Psychotic Symptoms.

Authors:  Josiane Bourque; Mohammad H Afzali; Patricia J Conrod
Journal:  JAMA Psychiatry       Date:  2018-08-01       Impact factor: 21.596

8.  Advanced paternal age and risk of psychotic-like symptoms in adult offspring.

Authors:  Julia Foutz; Briana Mezuk
Journal:  Schizophr Res       Date:  2015-05-09       Impact factor: 4.939

9.  Classes of psychotic experiences in Kenyan children and adolescents.

Authors:  Daniel Mamah; Akinkunle Owoso; Anne W Mbwayo; Victoria N Mutiso; Susan K Muriungi; Lincoln I Khasakhala; Deanna M Barch; David M Ndetei
Journal:  Child Psychiatry Hum Dev       Date:  2013-06

10.  Diagnostic efficiency of the CBCL thought problems and DSM-oriented psychotic symptoms scales for pediatric psychotic symptoms.

Authors:  Stephanie Salcedo; Sabeen H Rizvi; Lindsey K Freeman; Jennifer K Youngstrom; Robert L Findling; Eric A Youngstrom
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-03-20       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.